title: Diabetes and aspirin: beware of underpowered negative trials.
authors.forename: Michael E
authors.initials: ME
authors.lastname: Farkouh
authors.forename: Valentin
authors.initials: V
authors.lastname: Fuster
mesh_terms: D001241:Aspirin / Q000627:therapeutic use*; D002986:Clinical Trials as Topic / Q000379:methods*; D048909:Diabetes Complications / Q000517:prevention & control*; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D009203:Myocardial Infarction / Q000517:prevention & control*; D018579:Patient Selection; D017410:Practice Guidelines as Topic; D018401:Sample Size; D016896:Treatment Outcome
chemical_list: D005343:Fibrinolytic Agents; D001241:Aspirin